The cardiac troponin global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Cardiac Troponin Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The cardiac troponin market size has grown rapidly in recent years. It will grow from $3.49 billion in 2023 to $3.85 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increasing awareness and early diagnosis of heart conditions, expanding healthcare infrastructure in emerging markets, growth in the elderly population, introduction of high-sensitivity cardiac troponin assays.
The cardiac troponin market size is expected to see rapid growth in the next few years. It will grow to $5.73 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related cardiovascular conditions, expansion of cardiac care units in hospitals, increasing adoption of home healthcare, growth in personalized medicine, and demand for more efficient and cost-effective diagnostic solutions. Major trends in the forecast period include adoption of machine learning algorithms for data interpretation in cardiac care, expanding applications of cardiac troponin beyond acute coronary syndrome, advancements in multiplex testing for simultaneous biomarker analysis, development of novel biomarkers alongside troponin, and personalized medicine.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cardiac-troponin-global-market-report
Scope Of Cardiac Troponin Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Cardiac Troponin Market Overview
Market Drivers –
The increasing prevalence of heart-related conditions is expected to propel the growth of the cardiac troponin market going forward. Heart-related conditions encompass a range of cardiovascular diseases, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects, affecting the structure and function of the heart. The increasing prevalence of heart-related conditions is driven by factors such as aging populations, sedentary lifestyles, poor dietary habits, and rising rates of obesity and hypertension. Cardiac troponin is crucial in diagnosing heart-related conditions by serving as a highly sensitive biomarker for detecting heart muscle damage, particularly in cases of heart attacks and other cardiac events. For instance, according to the Report on Registration of Births and Deaths 2023 by the Registry of Births and Deaths, Immigration and Checkpoints Authority, Singapore and Ministry Of Health, the total number of deaths attributed to ischemic heart diseases reached 5,302, reflecting a slight increase from 5,290 recorded in 2022. Therefore, the increasing prevalence of heart-related conditions will drive the growth of the cardiac troponin market.
Market Trends –
Major companies operating in the cardiac troponin market are focusing on developing new technology, such as human serum-based quality control, to ensure accurate and reliable high-sensitivity troponin testing by providing multi-analyte controls. Human serum-based quality control in cardiac troponin testing ensures test accuracy and reliability by using human serum with known troponin concentrations to verify the assay’s performance. For instance, in May 2023, Bio-Rad Laboratories, Inc., a US-based biotechnology research company, introduced Cardiac Advance, a four-level, multi-analyte quality control specifically designed for high-sensitivity troponin testing. These liquid, human-serum-based controls are offered in InteliQ 3-mL tubes, Liquichek 3-mL standard, and 2.5-mL compact vials. The controls feature 10 cardiac analytes, including troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with Siemens and Roche testing platforms. The products are available in the U.S., Europe, and selected Asian markets.
The cardiac troponin market covered in this report is segmented –
1) By Type: Troponin I, Troponin T
2) By Location Of Testing: Laboratory Setting, Point Of Care (Poc) Testing
3) By Application: Acute Coronary Syndrome, Myocardial Infraction, Congestive Heart Failure, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Homecare Setting, Other End Users
Get an inside scoop of the cardiac troponin market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18986&type=smp
Regional Insights –
North America was the largest region in the cardiac troponin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMérieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC
Table of Contents
1. Executive Summary
2. Cardiac Troponin Market Report Structure
3. Cardiac Troponin Market Trends And Strategies
4. Cardiac Troponin Market – Macro Economic Scenario
5. Cardiac Troponin Market Size And Growth
…..
27. Cardiac Troponin Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
